Lista de obras - Everett E. Vokes - Dominio Público Uruguay

35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy

artículo científico publicado el 1 de octubre de 1992

5-Fluorouracil cardiotoxicity: a critical review

artículo científico publicado en 1990

5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer

artículo científico publicado en 1990

5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysis

artículo científico publicado en 1993

5-fluorouracil plus radiation for head and neck cancer

artículo científico publicado en 1995

5-fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study ⬇️

artículo científico publicado el 1 de enero de 1992

9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium

artículo científico publicado en 2004

A Phase I study of raltitrexed and paclitaxel given every 3 weeks to patients with solid tumors

artículo científico publicado en 1999

A Phase II Study of Halichondrin B Analog Eribulin Mesylate (E7389) in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with a Taxane: A California Cancer Consortium Trial ⬇️

artículo científico publicado el 1 de marzo de 2012

A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307 ⬇️

artículo científico publicado el 1 de octubre de 2010

A Phase II Trial of Vinorelbine in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck ⬇️

artículo científico publicado el 1 de agosto de 1998

A Phase II study of oxaliplatin in urothelial cancer

artículo científico publicado en 2005

A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma

artículo científico publicado en 2004

A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain

artículo científico publicado en 2003

A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer

artículo científico publicado en 2009

A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation ⬇️

artículo científico publicado el 26 de octubre de 2012

A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer

artículo científico publicado en 2000

A phase I study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients ⬇️

artículo científico publicado el 1 de enero de 1991

A phase I study of intermittent infusion cladribine in patients with solid tumors

artículo científico publicado en 1994

A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days

artículo científico publicado en 1999

A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer

scientific article published on 01 January 2007

A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer

artículo científico publicado en 2002

A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest

artículo científico publicado en 1995

A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer

artículo científico publicado en 2007

A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest

artículo científico publicado en 2001

A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer

artículo científico publicado en 2000

A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer

artículo científico publicado en 1995

A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer

artículo científico publicado en 1998

A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer

artículo científico publicado en 2003

A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.

artículo científico publicado en 2009

A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design

artículo científico publicado en 1994

A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602).

artículo científico publicado en 2010

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

artículo científico publicado en 2015

A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma

artículo científico publicado en 2007

A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.

artículo científico publicado en 2012

A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer.

artículo científico publicado en 2004

A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer

scientific article published on 01 May 1991

A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer

artículo científico publicado el 1 de enero de 1998

A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia

artículo científico publicado en 2010

A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer

artículo científico publicado en 2001

A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma

artículo científico publicado en 2006

A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531 ⬇️

artículo científico publicado el 6 de mayo de 2011

A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.

artículo científico publicado en 2006

A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer

artículo científico publicado en 2004

A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734.

artículo científico publicado en 2007

A phase I–II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer ⬇️

artículo científico publicado el 1 de junio de 1998

A phase-ii trial of neoadjuvant chemotherapy and concomitant chemoradiotherapy for the treatment of locally advanced nonsmall cell lung-cancer ⬇️

artículo científico publicado el 1 de septiembre de 1994

A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer

scientific article published on 04 September 2019

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.

artículo científico publicado en 2002

A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients

artículo científico publicado en 2018

A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.

artículo científico publicado en 2013

A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin-induced hypomagnesaemia

artículo científico publicado en 1990

A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer

artículo científico publicado en 2004

A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

scientific article published on 19 February 2020

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study

artículo científico publicado en 2020

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers ⬇️

artículo científico publicado el 17 de febrero de 2011

A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma

artículo científico publicado en 2006

A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases

artículo científico publicado en 2006

A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer

artículo científico publicado en 1990

A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer

artículo científico

A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: psychosocial aspects

artículo científico publicado en 1989

A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores

artículo científico publicado en 2007

A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung

artículo científico publicado el 1 de febrero de 1998

AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines

artículo científico publicado en 2016

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer

artículo científico publicado en 2015

ALK and ROS1 rearrangement in NSCLC: rapidly evolving standards

artículo científico publicado en 2017

Abstract 2746: An evaluation of poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer

Abstract 4919: Pathway profiling of head and neck cancer cell lines

Abstract LB-398: Detection of copy number alterations in 124 head and neck squamous cell carcinomas using the Nanostring nCounter assay

Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial

artículo científico publicado en 2000

Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer

artículo científico publicado en 2005

Adjuvant and neoadjuvant treatments for NSCLC.

artículo científico publicado en 2002

Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies ⬇️

artículo científico publicado el 26 de julio de 2011

Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer ⬇️

artículo científico publicado el 9 de octubre de 2010

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

artículo científico publicado en 2008

Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience

artículo científico publicado en 2020

Advancing current treatments for cancer.

artículo científico publicado en 1996

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

artículo científico publicado en 2003

An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck.

artículo científico publicado en 2002

An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease

scientific article published on 01 August 2008

An update on North American randomized studies in non-small cell lung cancer

artículo científico publicado el 1 de agosto de 1998

Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment

artículo científico publicado en 2004

Anaplastic carcinoma of the thyroid

scientific article published on 01 September 1996

Angiogenesis inhibition in the treatment of lung cancer.

artículo científico publicado en 2006

Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers

artículo científico publicado en 2006

Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium

artículo científico publicado en 2008

Aspiration in chemoradiated patients with head and neck cancer

scientific article published on December 2007

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study

artículo científico publicado en 2008

Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck

artículo científico publicado en 1999

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol

scientific article published on 27 October 2020

Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).

artículo científico publicado en 2011

CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer

artículo científico publicado en 2014

CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases

artículo científico publicado en 2010

CHART for non-small-cell lung cancer-promises and limitations ⬇️

artículo científico publicado el 19 de julio de 1997

CI-980 in advanced melanoma and hormone refractory prostate cancer

artículo científico publicado en 2000

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 ⬇️

artículo científico publicado el 1 de abril de 2012

Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer

artículo científico publicado en 2010

Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study

artículo científico publicado en 2002

Cardiac gallium uptake in doxorubicin-induced cardiotoxicity

artículo científico publicado en 1986

Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium ⬇️

artículo científico publicado el 23 de julio de 2012

Cellular and molecular mechanisms of radioresistance.

artículo científico publicado en 1995

Cetuximab in cancers of the lung and head & neck

artículo científico publicado en 2004

Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer

artículo científico publicado en 2008

Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck

artículo científico publicado en 2017

CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer

artículo científico publicado en 2018

Chemoprevention in head and neck cancer

artículo científico publicado en 2001

Chemoradiation for locally advanced, unresectable NSCLC. New standard of care, emerging strategies

artículo científico publicado en 1999

Chemoradiation for patients with advanced oral cavity cancer

artículo científico publicado en 2010

Chemoradiation for patients with large‐volume laryngeal cancers ⬇️

artículo científico publicado el 3 de noviembre de 2011

Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial ⬇️

artículo científico publicado el 1 de septiembre de 2010

Chemoradiotherapy for locally advanced head and neck cancer

artículo científico publicado en 2007

Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue

artículo científico publicado en 2010

Chemoreirradiation for recurrent salivary gland malignancies

artículo científico publicado en 2010

Chemotherapeutic and biologic radiation enhancement ⬇️

artículo científico publicado el 1 de diciembre de 1991

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).

artículo científico publicado en 2015

Chemotherapy and combined modality therapy in head and neck cancer.

artículo científico publicado en 1993

Chemotherapy and integrated treatment approaches in head and neck cancer

artículo científico publicado en 1991

Chemotherapy for non-small cell lung cancer. The continuing challenge

artículo científico publicado en 1991

Chemotherapy for stage IV non-small cell lung cancer

artículo científico publicado en 1990

Chemotherapy in head and neck cancer

artículo científico publicado en 1992

Chemotherapy in the management of squamous-cell carcinoma of the head and neck

artículo científico publicado en 2001

Chemotherapy of squamous cell carcinoma of head and neck: the future is now.

artículo científico publicado en 1996

Chemotherapy, biologics, and chemoprevention as systemic therapies for head and neck cancer.

artículo científico publicado en 1994

Chemotherapy-related hemolytic-uremic syndrome after the treatment of head and neck cancer. A case report

artículo científico publicado en 1990

Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution

scientific article published on 01 August 1991

Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer

artículo científico publicado en 1989

Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer

artículo científico publicado en 1988

Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis

artículo científico publicado en 1993

Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study

artículo científico publicado en 2011

Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

artículo científico publicado en 2005

Clinical Studies in Non-small Cell Lung Cancer: The CALGB Experience ⬇️

artículo científico publicado el 1 de enero de 1998

Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing

artículo científico publicado en 1989

Clinical prognostic model for older patients with advanced non-small cell lung cancer

artículo científico publicado en 2019

Clinical studies of docetaxel (Taxotere) and concomitant chest therapy

artículo científico publicado el 1 de agosto de 1997

Combination regimens and dose intensification in non-small cell lung cancer: a panel discussion (Part 1)

scientific article published on 01 April 1996

Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer

artículo científico publicado en 2013

Combined modality therapy in non-small cell lung and esophageal cancer: a phase I dose-escalation study of docetaxel with concurrent radiotherapy

artículo científico publicado el 1 de junio de 1998

Combined modality therapy of head and neck cancer.

artículo científico publicado en 1994

Combined modality therapy of solid tumours.

artículo científico publicado en 1997

Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity

artículo científico publicado en 2004

Combined-modality therapy of head and neck cancer

artículo científico publicado el 1 de septiembre de 1997

Combining radiotherapy with systemic therapies.

artículo científico publicado en 2008

Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling

artículo científico publicado en 2016

Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades

artículo científico publicado en 2014

Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy

artículo científico publicado en 2004

Competing roads to larynx preservation

artículo científico publicado en 2013

Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation

artículo científico publicado en 2016

Concomitant 5-FU, hydroxyurea and cisplatin with external beam radiation therapy for locally advanced pancreatic cancer ⬇️

artículo científico publicado el 1 de septiembre de 1997

Concomitant Chemoradiotherapy With Cisplatin, 5-Fluorouracil and Hydroxyurea in Poor-Prognosis Head and Neck Cancer ⬇️

artículo científico publicado el 1 de junio de 1992

Concomitant chemoradiotherapy as investigational therapy for locoregionally advanced head and neck cancer

artículo científico publicado el 1 de enero de 1992

Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer

artículo científico publicado en 2000

Concomitant chemoradiotherapy for non-small cell lung cancer

artículo científico publicado en 1994

Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme.

artículo científico publicado en 1995

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors

artículo científico publicado en 1990

Concomitant hydroxyurea, 5-fluorouracil, and radiation therapy for recurrent head and neck cancer: early results

artículo científico publicado en 1988

Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer

artículo científico publicado en 2001

Concurrent Chemotherapy and Intensity-Modulated Radiotherapy for Organ Preservation of Locoregionally Advanced Oral Cavity Cancer ⬇️

artículo científico publicado el 1 de agosto de 2011

Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary

artículo científico publicado en 2003

Concurrent chemoradiotherapy for head and neck cancer

artículo científico publicado en 2004

Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer

artículo científico publicado en 2005

Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer

artículo científico publicado en 2008

Considerations for the combined use of chemotherapy and radiation therapy

artículo científico publicado en 1995

Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer

artículo científico publicado en 1997

Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer

artículo científico publicado el 1 de enero de 1992

Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?

artículo científico publicado en 2008

Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer

artículo científico publicado en 2008

Cooperative group research efforts in lung cancer: focus on early-stage non-small-cell lung cancer

artículo científico publicado en 2008

Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress

artículo científico publicado en 2009

Cooperative group research endeavors in small-cell lung cancer: current and future directions

artículo científico publicado en 2009

Correction: CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases.

artículo científico publicado en 2011

Critical Role for the Receptor Tyrosine Kinase EPHB4 in Esophageal Cancers ⬇️

artículo científico publicado el 24 de octubre de 2012

Crizotinib (PF02341066) as a ALK /MET inhibitor- Special Emphasis as a Therapeutic Drug Against Lung Cancer

artículo científico publicado en 2011

Curative treatment for advanced head and neck cancer in the community: has the time come?

scientific article published on 01 July 2002

Current strategies for locoregionally advanced unresectable non-small cell lung cancer.

artículo científico publicado en 1999

Current treatments and promising investigations in a multidisciplinary setting

artículo científico publicado en 2005

Cyclooxygenase-2 (COX-2) As a Predictive Marker for the Use of COX-2 Inhibitors in Advanced Non–Small-Cell Lung Cancer ⬇️

artículo científico publicado el 2 de abril de 2012

DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer

artículo científico publicado en 2014

Dasatinib in previously treated metastatic colorectal cancer: a phase II trial of the University of Chicago Phase II Consortium ⬇️

artículo científico publicado el 7 de mayo de 2011

Data modifications to phase I study of suramin

scientific article published on 01 September 1996

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience

scientific article published on 16 March 2018

Differences in clinical trial patient attributes and outcomes according to enrollment setting

artículo científico publicado en 2009

Differential expression of RON in small and non-small cell lung cancers

artículo científico

Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.

artículo científico publicado en 2017

Distribution and functional consequences of nucleotide polymorphisms in the 3'-untranslated region of the human Sep15 gene

artículo científico publicado en 2001

Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer

artículo científico publicado en 2001

Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer

scientific article published on 01 February 2001

Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial

artículo científico publicado en 2007

Does chemotherapy for head and neck cancer improve symptoms? ⬇️

artículo científico publicado el 1 de mayo de 1997

Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Post-Treatment Functional Outcomes

scientific article published on 17 April 2020

Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer

artículo científico publicado en 1995

Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies

artículo científico publicado en 2004

Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis ⬇️

artículo científico publicado el 1 de enero de 1991

Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer

artículo científico publicado en 2013

EGFR-based bioradiotherapy in SCCHN

artículo científico publicado en 2015

EGFR-directed treatments in SCCHN.

artículo científico publicado en 2013

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

artículo científico publicado en 2016

Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.

artículo científico publicado en 2005

Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial

artículo científico publicado en 2019

Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer

scientific article published on 01 July 2007

Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis

artículo científico publicado en 2013

Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.

artículo científico publicado en 2009

Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia

artículo científico publicado en 2008

Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy

artículo científico publicado en 2009

Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor

artículo científico publicado en 2018

Efficacy of the Multi-Kinase Inhibitor Enzastaurin Is Dependent on Cellular Signaling Context ⬇️

artículo científico publicado el 28 de septiembre de 2010

Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.

artículo científico publicado en 2008

Elimination pathways of [14C]losoxantrone in four cancer patients

scientific article published on 01 February 2001

Enhancing the therapeutic index of concomitant chemoradiotherapy for head and neck cancer ⬇️

artículo científico publicado el 1 de mayo de 1998

Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012

artículo científico publicado en 2016

EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation

artículo científico publicado en 2010

Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains?

scientific article published on 04 September 2019

Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines

artículo científico publicado en 1989

Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer

artículo científico publicado en 2010

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

artículo científico publicado en 2009

Escalating doses of interferon alpha-2A with cisplatin and concomitant radiotherapy: a phase I study

scientific article published on 01 January 1993

Esophageal cancer therapy: a decade of inertia

artículo científico publicado en 2001

Ethnic differences and functional analysis of MET mutations in lung cancer

artículo científico publicado en 2009

Etoposide combined with interferon alfa-2b: novel exploitation of established etoposide pharmacokinetics and pharmacodynamics

scientific article published on 01 March 1996

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer

artículo científico publicado en 2014

Evaluation of homoharringtonine efficacy in the treatment of squamous cell carcinoma of the head and neck: a phase II Illinois Cancer Council Study

artículo científico publicado en 1989

Evaluation of neuropathy in patients on suramin treatment

artículo científico publicado en 1997

Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer ⬇️

artículo científico publicado el 27 de enero de 2012

Evidence-based role of bevacizumab in non-small cell lung cancer

artículo científico publicado en 2013

Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab

artículo científico publicado en 2015

Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients.

artículo científico publicado en 2018

Expanding role of the medical oncologist in the management of head and neck cancer

scientific article published on 20 December 2007

Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer.

artículo científico publicado en 2018

Expression and mutational analysis of MET in human solid cancers

artículo científico publicado en 2008

Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma

artículo científico

Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck

scientific article published on 07 July 2009

Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer

artículo científico publicado en 2010

Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer

artículo científico publicado el 3 de junio de 1992

Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer

artículo científico publicado en 2017

Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non-Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance).

artículo científico publicado en 2017

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.

artículo científico publicado en 2016

Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I study ⬇️

artículo científico publicado el 1 de enero de 1991

Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I study

artículo científico publicado en 1993

Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea

scientific article published on 01 September 2000

Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study

scientific article published on 01 January 2000

Flow cytometry in hairy cell leukemia before and during interferon alfa-2b therapy

artículo científico publicado en 1987

Fluorouracil modulation in head and neck cancer

artículo científico publicado en 1993

Free-flap reconstruction in the doubly irradiated patient population

artículo científico publicado en 2008

Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma

artículo científico publicado en 2008

Gemcitabine and radiation therapy for non-small cell lung cancer

artículo científico publicado el 1 de agosto de 1998

Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium ⬇️

artículo científico publicado el 28 de agosto de 2010

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

artículo científico publicado en 2004

Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers

artículo científico publicado en 2011

HPV-Associated Head and Neck Cancer

artículo científico publicado en 2015

Hairy-cell leukemia associated with Hodgkin's disease: a case report

scientific article published on 01 April 1985

Head and neck cancer

artículo científico publicado en 1993

Head and neck cancer in 2010: Maximizing survival and minimizing toxicity

artículo científico publicado en 2011

Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer

artículo científico publicado en 2019

Heat shock proteins in normal and leukemic blood cells

artículo científico publicado en 1989

Heuristic value-based framework for lung cancer decision-making.

artículo científico publicado en 2018

High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial

artículo científico publicado en 2006

How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?

artículo científico publicado en 2000

Human Papillomavirus Expression and p53 Gene Mutations in Squamous Cell Carcinoma ⬇️

artículo científico publicado el 1 de noviembre de 1997

Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival

artículo científico

Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer

artículo científico publicado el 1 de junio de 1992

Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer

artículo científico publicado el 1 de junio de 1995

Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study

artículo científico publicado en 1989

Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer ⬇️

artículo científico publicado el 1 de febrero de 2012

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma

scholarly article by Lili Ren et al published 2019 in OncoImmunology

Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study

artículo científico publicado en 1996

Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago

artículo científico publicado en 1996

Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies

artículo científico publicado en 1996

Ifosfamide-based three-drug combination regimens in non-small cell lung cancer

artículo científico publicado el 1 de febrero de 1998

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study

artículo científico publicado en 2005

Immune subgroups and the tumor microenvironment as a potential new biomarker to assess response to immunotherapy

artículo científico publicado en 2019

Implantable venous access device: use in patients with advanced head and neck cancer

artículo científico publicado en 1988

Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial

artículo científico publicado en 2020

Improving outcomes in the treatment of locally-advanced NSCLC with gemcitabine

artículo científico publicado en 2005

Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels

artículo científico publicado en 2008

Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancer

artículo científico publicado en 2004

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.

artículo científico publicado en 2007

Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.

artículo científico publicado en 2003

Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease

artículo científico publicado en 1995

Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer

artículo científico publicado en 2001

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer

artículo científico publicado en 2003

Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer

artículo científico publicado en 2001

Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival ⬇️

artículo científico publicado el 1 de agosto de 1998

Induction chemotherapy for head and neck cancer: recent data ⬇️

artículo científico publicado el 1 de enero de 2010

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis ⬇️

artículo científico publicado el 1 de febrero de 1990

Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: A long-term analysis ⬇️

artículo científico publicado el 1 de junio de 1998

Induction chemotherapy: to use or not to use? That is the question

scientific article published on January 2009

Induction or consolidation systemic therapy in the multimodality treatment of unresectable locally advanced non-small cell lung cancer ⬇️

artículo científico publicado el 1 de diciembre de 2003

Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.

artículo científico publicado en 2005

Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma

artículo científico publicado en 2015

Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.

artículo científico publicado en 1995

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

artículo científico publicado en 2014

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

artículo científico publicado en 2014

Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer

artículo científico publicado en 1994

Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions

artículo científico publicado en 2006

Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure

artículo científico publicado en 2003

Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction

scientific article published on 01 March 1995

Interactions of chemotherapy and radiation

artículo científico publicado en 1993

Interferons and other cytokines in head and neck cancer

artículo científico publicado en 1995

Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235

artículo científico publicado en 2008

Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B ⬇️

artículo científico publicado el 1 de noviembre de 1992

Introduction: head and neck cancer

artículo científico publicado en 2008

Investigation chemotherapy in multimodality therapy of non-small cell lung cancer

artículo científico publicado el 1 de enero de 1992

Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer

artículo científico publicado en 1997

Irinogenetics: what is the right star?

artículo científico publicado en 2006

Is patient travel distance associated with survival on phase II clinical trials in oncology?

scientific article published on 01 September 2003

Keratoacanthomas and skin neoplasms associated with suramin therapy

artículo científico publicado en 1996

Key signaling pathways and targets in lung cancer therapy.

artículo científico publicado en 2007

Laboratory and clinical studies of biochemical modulation by hydroxyurea

artículo científico publicado el 1 de junio de 1992

Limited-sampling models for irinotecan pharmacokinetics-pharmacodynamics: prediction of biliary index and intestinal toxicity

artículo científico publicado en 1996

Locally advanced head and neck cancer

artículo científico publicado en 2001

Locally advanced non-small cell lung cancer

artículo científico publicado en 2001

Locally advanced non-small cell lung cancer: the past, present, and future

artículo científico publicado en 2008

Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy

scientific article published on 01 July 1993

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction ⬇️

artículo científico publicado el 21 de agosto de 2010

Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma

artículo científico publicado en 2005

Long-term response to crisnatol mesylate in patients with glioma

artículo científico publicado el 1 de enero de 1997

Long-term survival of patients with localized diffuse histiocytic lymphoma

scientific article published on 01 October 1985

Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.

artículo científico publicado en 2015

Lung cancer

scientific article published on 01 February 2000

Lung cancer-a fractal viewpoint

artículo científico publicado en 2015

MET and phosphorylated MET as potential biomarkers in lung cancer

artículo científico publicado en 2011

MET as a target for treatment of chest tumors

artículo científico publicado en 2008

MET/PKCbeta expression correlate with metastasis and inhibition is synergistic in lung cancer

scientific article published on January 2009

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance).

artículo científico publicado en 2017

Management of Early Head and Neck Cancer in Elderly Patients

artículo científico publicado en 2018

Management of cancer treatment-related diarrhea. Issues and therapeutic strategies

artículo científico publicado en 2000

Measurable impact: multimodality therapy of head and neck cancer ⬇️

artículo científico publicado el 30 de septiembre de 1993

Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea

artículo científico publicado en 1994

Mineralocorticoid insufficiency due to suramin therapy

artículo científico publicado en 1996

Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer

artículo científico publicado en 2005

Molecular targets to overcome radioresistance

artículo científico publicado en 1992

Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck

artículo científico publicado en 2004

Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer

artículo científico publicado en 1995

Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer ⬇️

artículo científico publicado el 1 de mayo de 2003

Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma ⬇️

artículo científico publicado el 4 de junio de 2012

Multimodality therapy for esophageal cancer: an emerging role

artículo científico publicado el 1 de julio de 1998

Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results

artículo científico publicado en 1999

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer

artículo científico publicado en 2015

Nasopharyngeal carcinoma

artículo científico publicado en 1997

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer

artículo científico publicado en 2004

Neck dissection planning based on postchemoradiation computed tomography in patients with head and neck cancer

artículo científico publicado en 2009

Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer

artículo científico publicado en 2009

Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: A feasible and active approach ⬇️

artículo científico publicado el 1 de enero de 1992

Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer

artículo científico publicado en 1989

Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study

artículo científico publicado en 1989

New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer

artículo científico

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).

artículo científico publicado en 2017

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

artículo científico publicado en 2016

Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use

artículo científico publicado en 2019

Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial

scientific article published on 27 June 2019

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

artículo científico publicado en 2015

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

artículo científico publicado en 2015

Nivolumab versus docetaxel in previously treated advanced non-small cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

artículo científico publicado en 2018

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.

artículo científico publicado en 2017

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

artículo científico publicado en 2018

Non-small-cell lung cancer. Toward the next plateau

artículo científico publicado en 1994

Non-small-cell lung cancer: then and now.

artículo científico publicado en 2013

Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer

artículo científico publicado en 2015

Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy.

artículo científico publicado en 2016

O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer

artículo científico publicado en 2013

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

scientific article published on 01 October 2019

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

scientific article published on 01 February 2019

OPTIMA—A Phase 2 Trial of Induction Chemotherapy Response-Stratified Radiation Therapy Dose and Volume De-escalation for HPV+ Oropharyngeal Cancer: Efficacy, Toxicity, and HPV Subtype Analysis

article

Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer ⬇️

artículo científico publicado el 1 de septiembre de 1992

Optimal therapy for unresectable stage III non-small-cell lung cancer

artículo científico publicado en 2005

Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives

scientific article published on 30 August 2020

Oral 5-FU alternatives for the treatment of head and neck cancer

artículo científico publicado en 1998

Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA.

artículo científico publicado en 2013

Oral chemotherapy in head and neck cancer

artículo científico publicado en 1999

Oral vinorelbine (Navelbine) in the treatment of advanced non-small cell lung cancer: a preliminary report

artículo científico publicado en 1994

Osteoradionecrosis of the jaws as a risk factor in radiotherapy: a report of an eight-year retrospective review ⬇️

artículo científico publicado el 1 de marzo de 1998

Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma

artículo científico publicado en 2012

Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe

artículo científico publicado en 2016

P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets): Track: Immunotherapy

artículo científico publicado en 2016

PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription

artículo científico publicado en 2009

PD-L1 Immunohistochemistry Assay Comparison Studies in Non-Small Cell Lung Cancer: Characterization of the 73-10 Assay

scientific article published on 27 April 2020

PROCLAIM: A Phase III Study of Pemetrexed, Cisplatin, and Radiation Therapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiation Therapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Locally Advanced Stage I

artículo científico publicado en 2009

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer

artículo científico publicado en 2016

PS01.05: Early and Persistent Oligoclonal T Cell Expansion Correlates with Durable Response to Anti-PD1 Therapy in NSCLC: Topic: Medical Oncology.

artículo científico publicado en 2016

Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer

scientific article published on 01 August 1995

Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer

artículo científico publicado en 1999

Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer

artículo científico publicado el 1 de agosto de 1997

Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532

artículo científico publicado en 2000

Palbociclib: a new partner for cetuximab?

scientific article published on 24 July 2019

Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer

artículo científico

Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience

artículo científico publicado en 2004

Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion

artículo científico publicado en 2008

Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer

artículo científico publicado en 2013

Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer

artículo científico publicado el 1 de abril de 1997

Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy ⬇️

artículo científico publicado el 22 de mayo de 2012

Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)

Peripheral blood mononuclear cell dihydropyrimidine dehydrogenase activity in volunteers with and without diabetes mellitus

artículo científico publicado en 1996

Personalized Treatment of Lung Cancer ⬇️

artículo científico publicado el 1 de abril de 2011

Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer

scientific article published on 01 August 1992

Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer

scientific article published on 01 May 1996

Pharmacoeconomics, quality of life, and combination modalities in non-small cell lung cancer: a panel discussion (Part 2).

artículo científico publicado en 1996

Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity

artículo científico publicado en 2008

Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients

artículo científico publicado en 1997

Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies

artículo científico publicado en 1999

Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance).

artículo científico publicado en 2018

Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.

artículo científico publicado en 1995

Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer

artículo científico publicado en 2004

Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904.

artículo científico publicado en 2009

Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer

artículo científico publicado en 2008

Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer

artículo científico publicado en 2005

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck ⬇️

artículo científico publicado el 1 de febrero de 1998

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck

artículo científico publicado en 2004

Phase I study of docetaxel with concomitant thoracic radiation therapy ⬇️

artículo científico publicado el 1 de enero de 1998

Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancer

artículo científico publicado en 2002

Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer

artículo científico publicado en 1999

Phase I study of escalating doses of mitoxantrone and paclitaxel with granulocyte-macrophage colony stimulating factor support

scientific article published on 01 June 1996

Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer

artículo científico publicado en 2008

Phase I study of suramin administered by intermittent infusion without adaptive control to cancer patients: update of two expanded dose levels near the maximally tolerated dose

artículo científico publicado en 1996

Phase I study of suramin given by intermittent infusion without adaptive control in patients with advanced cancer ⬇️

artículo científico publicado el 1 de septiembre de 1995

Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours

artículo científico publicado en 2002

Phase I study of treatment with oral 13-cis-retinoic acid, subcutaneous interferon alfa-2a, cisplatin, and 24-hour infusion 5-fluorouracil/leucovorin

artículo científico publicado en 1997

Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer

scientific article published on 01 March 1997

Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies ⬇️

artículo científico publicado el 1 de junio de 1998

Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer

artículo científico publicado en 2008

Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer

artículo científico publicado en 2007

Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer.

artículo científico publicado en 2003

Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer

artículo científico publicado en 2005

Phase II Study of Dasatinib in Patients with Previously Treated Malignant Mesothelioma (Cancer and Leukemia Group B 30601): A Brief Report ⬇️

artículo científico publicado el 1 de abril de 2012

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

article by Mark Agulnik et al published September 2007 in Journal of Clinical Oncology

Phase II Study of the Histone Deacetylase Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30304) ⬇️

artículo científico publicado el 1 de octubre de 2010

Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer ⬇️

artículo científico publicado el 1 de abril de 1998

Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck

artículo científico publicado en 2005

Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).

artículo científico publicado en 2008

Phase II studies of bryostatin-1 in patients with advanced sarcoma and advanced head and neck cancer

scientific article published on 01 January 2001

Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097).

artículo científico publicado en 2010

Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study

scientific article published on 01 January 1995

Phase II study of flavopiridol in patients with advanced colorectal cancer

artículo científico publicado en 2003

Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck ⬇️

artículo científico publicado el 17 de abril de 2012

Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center

scientific article published on 01 February 1997

Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206

artículo científico publicado en 2013

Phase II study of sunitinib malate in head and neck squamous cell carcinoma

artículo científico publicado en 2009

Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer

artículo científico publicado en 2003

Phase II trial of 150-minute weekly infusion of gemcitabine in advanced colorectal cancer: minimal activity in colorectal cancer

scientific article published on 01 January 1998

Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study

artículo científico publicado en 2004

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck

artículo científico publicado en 2003

Phase II trial of aminocamptothecin (9-AC/DMA) in patients with advanced squamous cell head and neck cancer

artículo científico publicado en 2000

Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer

artículo científico publicado en 2005

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

artículo científico publicado en 2015

Phase II trial of etoposide and doxorubicin in advanced head and neck cancer

artículo científico publicado en 1990

Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

artículo científico publicado en 2005

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

artículo científico publicado en 2001

Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902.

artículo científico publicado en 2006

Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus

artículo científico publicado en 2005

Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.

artículo científico publicado en 2008

Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer ⬇️

artículo científico publicado el 1 de junio de 1998

Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.

artículo científico publicado en 2007

Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck ⬇️

artículo científico publicado el 8 de marzo de 2011

Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer

artículo científico publicado en 2006

Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma

artículo científico publicado en 2005

Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced biliary carcinoma

artículo científico publicado en 1999

Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma

artículo científico publicado en 1998

Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study

artículo científico publicado en 1998

Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901.

artículo científico publicado en 2008

Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers

artículo científico publicado en 2005

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).

artículo científico publicado en 2017

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

artículo científico publicado en 2014

Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].

artículo científico publicado en 2009

Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group ⬇️

artículo científico publicado el 1 de marzo de 1998

Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers

artículo científico publicado en 2006

Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer

artículo científico publicado en 2014

Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.

artículo científico publicado en 2017

Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).

artículo científico publicado en 2015

Predictors of competing mortality in advanced head and neck cancer

artículo científico publicado en 2009

Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.

artículo científico publicado en 2013

Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.

artículo científico publicado en 1996

Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck

artículo científico publicado en 2004

Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation ⬇️

artículo científico publicado el 13 de junio de 2011

Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients

artículo científico publicado en 2004

Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy

artículo científico publicado en 1991

Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633.

artículo científico publicado en 2010

Progress in unresectable stage III non-small cell lung cancer

artículo científico publicado en 1996

Prolonging Life, but at What Price?

artículo científico publicado en 2019

Protein kinase C beta in malignant pleural mesothelioma

artículo científico publicado en 2008

Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database ⬇️

artículo científico publicado el 28 de febrero de 2011

Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemi

artículo científico publicado el 7 de abril de 2011

Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.

artículo científico publicado en 1999

Quantitative Imaging Study of Extent of Surgical Resection and Prognosis of Malignant Astrocytomas ⬇️

artículo científico publicado el 1 de noviembre de 1997

RATIONALE 001: Tislelizumab (BGB-A317) + concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC)

scientific article published on 01 April 2019

RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma ⬇️

artículo científico publicado el 1 de julio de 2011

Race and competing mortality in advanced head and neck cancer

artículo científico publicado en 2013

Radiation Therapy Oncology Group. Research Plan 2002-2006. Head and Neck Cancer Committee

artículo científico publicado el 1 de enero de 2001

Radiation Therapy Oncology Group. Research Plan 2002-2006. Medical Oncology Committee

artículo científico publicado el 1 de enero de 2001

Radiation therapy in head and neck cancer: indications and limitations.

artículo científico publicado en 1994

Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer

artículo científico publicado en 1999

Radioresistant tumor cell lines derived from head and neck radiation failures

scientific article published on 01 July 1989

Radiotherapy with concomitant chemotherapy for head and neck cancer

artículo científico publicado en 1991

Radiotherapy: Accelerated radiotherapy for HNSCC in developing countries

artículo científico publicado el 1 de noviembre de 2010

Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901

scientific article published on 03 July 2020

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer

artículo científico publicado en 1994

Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.

artículo científico publicado en 2008

Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.

artículo científico publicado en 2002

Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407.

artículo científico publicado en 2011

Randomized phase II trial of docetaxel plus cetuximab or docetaxel plus bortezomib in patients with advanced non-small-cell lung cancer and a performance status of 2: CALGB 30402.

artículo científico publicado en 2009

Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial

artículo científico publicado en 2012

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

artículo científico publicado en 2008

Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

artículo científico publicado en 2005

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer

artículo científico publicado en 2001

Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.

artículo científico publicado en 2000

Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.

artículo científico publicado en 2006

Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma

artículo científico publicado en 2014

Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease

artículo científico publicado en 1996

Recent advances in radiation therapy for head and neck cancer

artículo científico publicado en 1991

Recommended guidelines for the treatment of cancer treatment-induced diarrhea

artículo científico publicado en 2004

Recommended guidelines for the treatment of chemotherapy-induced diarrhea ⬇️

artículo científico publicado el 1 de septiembre de 1998

Reply to s. Chakraborty et al

artículo científico publicado en 2015

Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation

artículo científico publicado en 2011

Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.

artículo científico publicado en 2005

Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.

artículo científico publicado en 2008

Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer

artículo científico publicado en 2016

Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer

artículo científico publicado en 2014

Role of dental hardware in oral cavity squamous cell carcinoma in the low-risk nonsmoker nondrinker population

artículo científico publicado en 2018

Role of protein kinase C β and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism ⬇️

artículo científico publicado el 3 de marzo de 2011

Role of systemic therapy in advanced non-small-cell lung cancer

scientific article published on December 1990

Searching for a standard

artículo científico publicado en 2002

Second malignancies in hairy cell leukemia

artículo científico publicado en 1985

Seeking improved outcome in the curative treatment of non-small-cell lung cancer

artículo científico publicado en 2005

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.

artículo científico publicado en 2016

Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time

artículo científico publicado en 2004

Sequential administration of methotrexate, cisplatin, and 5-fluorouracil in multimodal therapy for locally advanced head and neck cancer

artículo científico publicado en 1988

Sequential combined modality therapy for stage III non-small cell lung cancer

artículo científico publicado en 1990

Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer

artículo científico publicado en 2001

Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304 ⬇️

artículo científico publicado el 1 de noviembre de 2011

Serum immunoerythropoietin levels in patients with cancer receiving cisplatin-based chemotherapy

artículo científico publicado en 1991

Sex-associated differences in survival of patients undergoing resection for lung cancer

artículo científico publicado en 2000

Should non-small cell carcinoma of the lung be treated with chemotherapy? Pro: chemotherapy is for non-small cell lung cancer.

artículo científico publicado en 1995

Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B.

artículo científico publicado en 2005

Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of in vitro expanded populations in head and neck cancer

artículo científico publicado en 2017

Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation

artículo científico publicado en 2006

Somatic acquisition and signaling of TGFBR1*6A in cancer

artículo científico publicado en 2005

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease

artículo científico publicado en 2011

Suramin: is adaptive control necessary? ⬇️

artículo científico publicado el 1 de diciembre de 1992

Surgical management of the head and neck cancer patient following concomitant multimodality therapy

artículo científico publicado en 1995

Survival and analysis of failure following hydroxyurea, 5-fluorouracil and concomitant radiation therapy in poor prognosis head and neck cancer

artículo científico publicado en 1991

Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy

artículo científico publicado en 2013

Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review

artículo científico publicado en 2003

Swallowing function following multispecialty organ preservation treatment of advanced head and neck-cancer ⬇️

artículo científico publicado el 1 de mayo de 1994

Swallowing function in patients with head and neck cancer prior to treatment

scientific article published on 01 March 2000

Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non–Small-Cell Lung Cancer, A Phase II Trial

artículo científico publicado en 2011

Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality setting

artículo científico publicado en 2003

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium

artículo científico publicado en 2010

The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium

scientific article published on 01 January 2007

The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target

artículo científico publicado en 2013

The Impact of Staging by Positron-Emission Tomography on Overall Survival and Progression-Free Survival in Patients With Locally Advanced NSCLC

artículo científico publicado en 2018

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma

artículo científico publicado en 2009

The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity

artículo científico publicado en 1996

The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC.

artículo científico publicado en 2016

The cancer and leukemia group B respiratory committee

artículo científico publicado en 2006

The chemoradiation paradigm in head and neck cancer

artículo científico publicado en 2007

The concurrent chemoradiation paradigm--general principles

artículo científico publicado en 2007

The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium

artículo científico publicado en 2009

The evolving role of systemic therapy in carcinoma of the lung

artículo científico publicado el 1 de agosto de 1992

The expanding role of systemic therapy in head and neck cancer

artículo científico publicado en 2004

The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.

artículo científico publicado en 2001

The importance of quality-of-life measurements in oncology

artículo científico publicado en 2002

The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines

artículo científico publicado el 1 de enero de 1992

The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone

artículo científico publicado en 1989

The promise of biochemical modulation in combined modality therapy

artículo científico publicado en 1994

The role of EGFR inhibition in the treatment of non-small cell lung cancer

artículo científico publicado en 2009

The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.

artículo científico publicado en 2000

The role of paclitaxel in the treatment of head and neck cancer

artículo científico publicado en 1995

The standard to come: systemic therapies for systemic disease

scientific article published on 01 September 1995

The transfacial approach for combined anterior craniofacial tumor ablation

artículo científico publicado en 1989

The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer

artículo científico publicado en 2000

Therapeutic options for laryngeal cancer

artículo científico publicado en 2003

Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer

scientific article published on 01 February 1997

Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer

artículo científico publicado en 1994

Timing and sequencing of chemoradiotherapy

artículo científico publicado en 1995

Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer

article

Treatment of hairy cell leukemia with recombinant alpha 2 interferon

artículo científico publicado en 1985

Treatment of head and neck and esophageal xenografts employing Alimta and concurrent ionizing radiation

artículo científico publicado en 2001

Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cance

artículo científico publicado en 2009

Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy

artículo científico publicado en 2005

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

artículo científico publicado en 2002

Update in head and neck oncology

artículo científico publicado en 2004

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.

artículo científico publicado en 2018

Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma

artículo científico publicado en 2012

Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials

artículo científico publicado en 2017

Validation of survival prognostic models for non-small-cell lung cancer in stage- and age-specific groups

artículo científico publicado en 2015

Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: the University of Chicago experience

artículo científico publicado en 1991

Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107) ⬇️

artículo científico publicado el 22 de diciembre de 2011

Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study

scientific article published on 01 April 1996

Volumetric visualization of head and neck CT data for treatment planning

artículo científico publicado en 1999

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer

artículo científico publicado en 2003

[Advances in the treatment of head and neck tumors. 2. Radiochemotherapy]

scientific article published on 01 March 1995

[Advances in the treatment of head and neck tumors. I. Chemotherapy]

scientific article published on 01 January 1995

p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines

scientific article published on 01 August 1993

Lista de obras de Everett E. Vokes

35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy

5-Fluorouracil cardiotoxicity: a critical review

5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer

5-Fluorouracil, hydroxyurea and escalating doses of iododeoxyuridine with concomitant radiotherapy for malignant gliomas: a clinical and pharmacologic analysis

5-fluorouracil plus radiation for head and neck cancer

5-fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study ⬇️

9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium

A Phase I study of raltitrexed and paclitaxel given every 3 weeks to patients with solid tumors

A Phase II Study of Halichondrin B Analog Eribulin Mesylate (E7389) in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with a Taxane: A California Cancer Consortium Trial ⬇️

A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307 ⬇️

A Phase II Trial of Vinorelbine in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck ⬇️

A Phase II study of oxaliplatin in urothelial cancer

A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma

A case study documenting the anticancer activity of ZD1839 (Iressa) in the brain

A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer

A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation ⬇️

A phase I study of STEALTH cisplatin (SPI-77) and vinorelbine in patients with advanced non small-cell lung cancer

A phase I study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients ⬇️

A phase I study of intermittent infusion cladribine in patients with solid tumors

A phase I study of oral uracil/ftorafur (UFT) plus leucovorin and bis-acetato-ammine-dichloro-cyclohexylamine-platinum IV (JM-216) each given over 14 days every 28 days

A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer

A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer

A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest

A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer

A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest

A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer

A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer

A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer

A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer

A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.

A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design

A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602).

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma

A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.

A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer.

A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer

A phase II study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer

A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia

A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer

A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma

A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531 ⬇️

A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.

A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer

A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734.

A phase I–II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer ⬇️

A phase-ii trial of neoadjuvant chemotherapy and concomitant chemoradiotherapy for the treatment of locally advanced nonsmall cell lung-cancer ⬇️

A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer

A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer.

A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients

A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.

A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin-induced hypomagnesaemia

A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer

A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study

A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers ⬇️

A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma

A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases

A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer

A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer

A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: psychosocial aspects

A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores

A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung

AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer

ALK and ROS1 rearrangement in NSCLC: rapidly evolving standards

Abstract 2746: An evaluation of poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer

Abstract 4919: Pathway profiling of head and neck cancer cell lines

Abstract LB-398: Detection of copy number alterations in 124 head and neck squamous cell carcinomas using the Nanostring nCounter assay

Activity of docetaxel in platinum-treated non-small-cell lung cancer: results of a phase II multicenter trial

Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer

Adjuvant and neoadjuvant treatments for NSCLC.

Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies ⬇️

Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer ⬇️

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience

Advancing current treatments for cancer.

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck.